CorMatrix outer membrane patch approved by FDA

Headquartered in Roswell, Georgia, USA, CorMatrix Cardiovascular is a medical device company that develops biomaterial equipment, co-founded in December 2001 by Cardiovascular Surgeon DrRobert GMatheny and Cardiovascular Medical Device entrepreneur David CampThe company uses proprietary technology to develop devices that repair human heart tissue, and its proprietary technology is an extracellular matrix (ECM) technology that solves medical problems in clinical applications related to congestive heart failure, heart valves and cardiovascular disease, the company's six related equipment has been involved in more than 220,000 cardiovascular regeneration operationsCorMatrix Cardiovascular is developing second-generation ECM technology, and the approved Cor Patch extramyr repair subsidy represents the company's formal entry into the next generation of ECM heart surgery market, CorMatrix Cardiovascular, said on its website that the patch minimizes the inflammatory response after implantation and has the structural support required for the structure of the outer membraneCor Patch is available in five packages, as well as 5cm x 5cm and 7cm x 10cmNote: The original text has a limitation